| Document Date: 2014-10-27 00:38:24
Open Document File Size: 1,78 MBShare Result on Facebook
Company Alcon Laboratories (Australia) Pty Ltd / / Country Australia / / IndustryTerm healthcare resources / decision analytic protocol / / MedicalCondition macular hole / macular holes / diabetic retinopathy / Vitreoretinal interface disorders / Vitreomacular interface disorders / posterior vitreous detachment / retinal vascular disease / full thickness macular hole / central blindness / VMA/VMT/FTMH disease / sVMA/FTMH disease / metamorphopsia / wet Age-Related Macular Degeneration AMD / macular epiretinal membrane / / MedicalTreatment drug therapy / surgery / / Organization Medical Services Advisory Committee / Medicare / Therapeutic Goods Administration / / Position Commonwealth Minister / Government Health Minister / / Product pseudo / / Technology draft Protocol / decision analytic protocol / diagnostic tests / tomography / 1370 Consultation Protocol / /
SocialTag |
1370 Consultation Protocol to guide the assessment of optical coherence tomography for the determination of eligibility and efficacy assessment of treatment with ocriplasmin (JETREA®)